• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建一种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒系统以体外研究病毒生命周期

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro.

作者信息

Wang Jiaming, Dai Wenxin, Zhou Shuqi, Ma Wenfu

机构信息

School of Life Sciences, Beijing University of Chinese Medicine.

School of Life Sciences, Beijing University of Chinese Medicine;

出版信息

J Vis Exp. 2025 Jun 6(220). doi: 10.3791/68389.

DOI:10.3791/68389
PMID:40549572
Abstract

The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) virus-like particle (SC2-VLP) method offers a powerful and accessible tool for studying the SARS-CoV-2 life cycle without the need for biosafety level 3 (BSL-3) laboratories. This system effectively mimics critical stages of the viral life cycle, including assembly, genome packaging, and egress, using a luciferase reporter fused to the T20 signal for sensitive and precise detection of viral particle production. SC2-VLPs are generated by co-expressing SARS-CoV-2 structural proteins, including membrane (M), nucleocapsid (N), envelop (E), and spike (S), along with the RNA packaging signal in HEK-293T cells. Unlike traditional virus-like particle systems, the SC2-VLP method ensures accurate quantification and greater fidelity to the natural viral life cycle. Furthermore, compared to lentiviral pseudotyping methods, which are limited to studying viral entry through the incorporation of S protein into HIV-based lentiviral particles, the SC2-VLP system provides a more comprehensive platform for exploring multiple stages of SARS-CoV-2 biology. While this method bypasses the risks of handling live virus and expands accessibility. The SC2-VLP method represents a significant advancement in antiviral research and the development of therapeutic strategies against SARS-CoV-2.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒(SC2-VLP)方法提供了一种强大且易于使用的工具,用于研究SARS-CoV-2的生命周期,而无需生物安全3级(BSL-3)实验室。该系统使用与T20信号融合的荧光素酶报告基因,有效模拟病毒生命周期的关键阶段,包括组装、基因组包装和释放,以灵敏且精确地检测病毒颗粒的产生。SC2-VLPs是通过在HEK-293T细胞中共表达SARS-CoV-2结构蛋白(包括膜蛋白(M)、核衣壳蛋白(N)、包膜蛋白(E)和刺突蛋白(S))以及RNA包装信号而产生的。与传统的病毒样颗粒系统不同,SC2-VLP方法可确保准确量化并更忠实地模拟天然病毒生命周期。此外,与慢病毒假型化方法相比,慢病毒假型化方法仅限于通过将S蛋白掺入基于HIV的慢病毒颗粒中来研究病毒进入,而SC2-VLP系统为探索SARS-CoV-2生物学的多个阶段提供了更全面的平台。虽然这种方法规避了处理活病毒的风险并扩大了可及性,但SC2-VLP方法代表了抗病毒研究以及针对SARS-CoV-2治疗策略开发方面的一项重大进展。

相似文献

1
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro.构建一种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒系统以体外研究病毒生命周期
J Vis Exp. 2025 Jun 6(220). doi: 10.3791/68389.
2
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.小鼠血管紧张素转换酶2(ACE2)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染易感性的决定因素。
J Virol. 2025 Jun 17;99(6):e0054325. doi: 10.1128/jvi.00543-25. Epub 2025 May 12.
3
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内 SARS-CoV-2 宿主内基因进化特征分析
J Virol. 2025 Jun 17;99(6):e0048225. doi: 10.1128/jvi.00482-25. Epub 2025 May 6.
4
Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules.新兴的 SARS-CoV-2 抗病毒策略:从解析病毒蛋白结构功能到疫苗、抗体和小分子药物的开发。
Int J Mol Sci. 2022 May 29;23(11):6083. doi: 10.3390/ijms23116083.
5
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells.光的泛变体潜力:425纳米的光可使新冠病毒变异株失活,且非细胞毒性剂量可降低人气道上皮细胞中的病毒滴度。
mSphere. 2025 Jun 25;10(6):e0023025. doi: 10.1128/msphere.00230-25. Epub 2025 May 28.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Colchicine for the treatment of COVID-19.秋水仙碱治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD015045. doi: 10.1002/14651858.CD015045.
10
Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的组装与进入:使用病毒样颗粒进行评估
Cells. 2021 Apr 9;10(4):853. doi: 10.3390/cells10040853.